ArticleCell death & disease2019

Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia.

Sofiane Berrazouane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.